Methylprednisolone, prednisone
Methylprednisolone, prednisone is a pharmaceutical drug with 5 clinical trials. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
33.3%
1 of 3 finished
66.7%
2 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection
Effect of Glucocorticoids on Inflammation and Bone Metabolism in Patients With Glomerular Disease
An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo
A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
Clinical Trials (5)
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection
Effect of Glucocorticoids on Inflammation and Bone Metabolism in Patients With Glomerular Disease
An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo
A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5